Intermolecular Inc Q2 2018 Institutional Investor Sentiment Worse Than Expected

November 10, 2018 - By Christine McCrea

Intermolecular, Inc. (NASDAQ:IMI) Logo

Sentiment for Intermolecular Inc (NASDAQ:IMI)

Intermolecular Inc (NASDAQ:IMI) institutional sentiment decreased to 0.89 in Q2 2018. Its down -0.55, from 1.44 in 2018Q1. The ratio is negative, as 8 institutional investors increased and opened new positions, while 9 cut down and sold their positions in Intermolecular Inc. The institutional investors in our partner’s database reported: 18.44 million shares, up from 18.13 million shares in 2018Q1. Also, the number of institutional investors holding Intermolecular Inc in their top 10 positions was flat from 0 to 0 for the same number . Sold All: 4 Reduced: 5 Increased: 4 New Position: 4.

Intermolecular, Inc. offers high productivity combinatorial technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company has market cap of $46.07 million. The Company’s HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established CVD, physical vapor deposition, and atomic layer deposition methods. It currently has negative earnings. It serves various markets, including flat glass, advanced alloys, light-emitting diodes, flat-panel displays, and others.

The stock decreased 22.83% or $0.2739 during the last trading session, reaching $0.9261. About 992,025 shares traded or 1041.49% up from the average. Intermolecular, Inc. (NASDAQ:IMI) has risen 42.05% since November 10, 2017 and is uptrending. It has outperformed by 26.43% the S&P500.

Raging Capital Management Llc holds 3.69% of its portfolio in Intermolecular, Inc. for 14.73 million shares. Symmetry Peak Management Llc owns 354,642 shares or 0.12% of their US portfolio. Moreover, Penbrook Management Llc has 0.06% invested in the company for 40,000 shares. The Massachusetts-based Essex Investment Management Co Llc has invested 0.03% in the stock. Rbf Capital Llc, a California-based fund reported 43,071 shares.

More news for Intermolecular, Inc. (NASDAQ:IMI) were recently published by: Benzinga.com, which released: “The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to …” on October 23, 2018. Seekingalpha.com‘s article titled: “Intermolecular, Inc. (IMI) CEO Chris Kramer on Q3 2018 Results – Earnings Call Transcript” and published on November 10, 2018 is yet another important article.

Intermolecular, Inc. (NASDAQ:IMI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: